Found: 5
Select item for more details and to access through your institution.
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
- Published in:
- Diabetologia, 2023, v. 66, n. 5, p. 813, doi. 10.1007/s00125-023-05876-w
- By:
- Publication type:
- Article
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32‐week randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1624, doi. 10.1111/dom.15464
- By:
- Publication type:
- Article
Evaluation of renal oxygenation by BOLD–MRI in high-risk patients with type 2 diabetes and matched controls.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 3, p. 691, doi. 10.1093/ndt/gfac186
- By:
- Publication type:
- Article
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 4, p. 328, doi. 10.1177/1479164119825761
- By:
- Publication type:
- Article